2024-11-04T11:25:13-06:00 2023-12-31 420714325 RSM US LLP 7351 OFFICE PARK PLACE MELBOURNE FL 329408229 990 2023-01-01 231682043 AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS AMER 7038366981 528 NORTH WASHINGTON STREET ALEXANDRIA VA 22314 ABIGAIL W GORMAN CHIEF EXECUTIVE OFFICER 7038366981 2024-11-01 1 0 KELLI PECK P01423033 3217516200 2024-11-01 2023 2024-10-15 13:58:12Z ABIGAIL W GORMAN 528 NORTH WASHINGTON STREET ALEXANDRIA VA 22314 6784925 0 X WWW.ASCPT.ORG X 1900 DC ADVANCING CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE AND THERAPEUTICS FOR THE BENEFIT OF PATIENTS AND SOCIETY. SIGNIFICANT ACTIVITIES INCLUDE THREE SCHOLARLY PEER-REVIEWED JOURNALS ALONG WITH ONLINE EDUCATIONAL OPPORTUNITIES. 11 11 12 600 3519 0 88469 58535 3456290 3514192 77202 120233 3815 7410 3625776 3700370 33250 60495 0 0 1920573 1870957 9907 0 0 1290343 2122107 3254073 4053559 371703 -353189 6502007 6491449 0 0 6502007 6491449 X ADVANCING CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE AND THERAPEUTICS FOR THE BENEFIT OF PATIENTS AND SOCIETY. 0 0 1705798 60495 1421105 ANNUAL MEETING: THE ASCPT ANNUAL MEETING IS AN INTERNATIONAL MEETING THAT ATTRACTS PARTICIPANTS FROM AROUND THE WORLD. A SPECTRUM OF TOPICS RELATING TO THE CONTINUUM OF DRUG DISCOVERY, DEVELOPMENT, REGULATION, AND UTILIZATION ARE DISCUSSED. THE MEETING OFFERS EDUCATIONAL SESSIONS AND POSTER PRESENTATIONS, LECTURES FROM TOP PROFESSIONALS IN THE FIELD, AS WELL AS NETWORKING OPPORTUNITIES WITH CLINICAL PHARMACOLOGISTS AND TRANSLATIONAL SCIENTISTS FROM AROUND THE WORLD. 1218480 1587243 "JOURNAL: CLINICAL PHARMACOLOGY AND THERAPEUTICS (CPT) IS THE AUTHORITATIVE CROSS-DISCIPLINARY JOURNAL IN EXPERIMENTAL AND CLINICAL MEDICINE DEVOTED TO PUBLISHING ADVANCES IN THE NATURE, ACTION, EFFICACY AND EVALUATION OF THERAPEUTICS. JOURNAL CLINICAL PHARMACOLOGY & THERAPEUTICS: PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY (PSP) IS A TIMELY ONLINE-ONLY CROSS-DISCIPLINARY JOURNAL PUBLISHING ADVANCES IN QUANTITATIVE METHODS AS APPLIED IN PHARMACOLOGY, PHYSIOLOGY AND THERAPEUTICS IN HUMANS. CPT HAS A 2023 IMPACT FACTOR OF 6.3. PSP HAS A 2023 IMPACT FACTOR OF 3.1.CLINICAL AND TRANSLATIONAL SCIENCE (CTS) HIGHLIGHTS ORIGINAL RESEARCH THAT HELPS BRIDGE LABORATORY DISCOVERIES WITH THE DIAGNOSIS AND TREATMENT OF HUMAN DISEASE. CTS HAS A 2023 IMPACT FACTOR OF 3.1." 664571 502325 MEMBER SERVICES: MEMBERSHIP IN ASCPT OFFERS A NUMBER OF BENEFITS WHICH DIRECTLY IMPACT ITS MEMBERS AND THEIR PROFESSIONAL DEVELOPMENT. IT PROVIDES A VARIETY OF INFORMATION AND TOOLS, SUCH AS THE CPT, PSP AND CTS JOURNALS, WEBINARS, WEBSITE AND EMAIL NEWSLETTER, EDUCATIONAL OPPORTUNITIES, SUCH AS THE ANNUAL MEETING, NETOWORKING OPPORTUNITIES, AND PROFESSIONAL DEVELOPMENT OPPORTUNITIES. 3588849 1 1 0 1 0 0 0 0 0 0 1 1 0 0 0 1 0 0 0 0 1 0 1 0 0 0 0 1 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 46 0 1 12 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 11 11 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 CA CO CT FL GA IL KS MA MD MO NC NJ NY PA TN TX VA WA WI HI WY X THE SOCIETY 7038366981 528 NORTH WASHINGTON STREET ALEXANDRIA VA 22314 WALTER KRAFT PRESIDENT 4.00 X X 0 0 0 MARK J DRESSER IMMEDIATE PAST PRESIDENT 4.00 X X 0 0 0 MATTHEW L RIZK PRESIDENT-ELECT 4.00 X X 0 0 0 JACQUES TURGEON TREASURER 4.00 X X 0 0 0 ANTOINETTE TONI AJAVON-HARTMANN DIRECTOR 4.00 X 0 0 0 LISA J BENINCOSA DIRECTOR 4.00 X 0 0 0 JING LIU DIRECTOR 4.00 X 0 0 0 KATHRYN MOMARY DIRECTOR 4.00 X 0 0 0 DANIELE OUELLET DIRECTOR 4.00 X 0 0 0 LUANA PESCO-KOPLOWITZ DIRECTOR 4.00 X 0 0 0 ANU RAMAMOORTHY DIRECTOR 4.00 X 0 0 0 ABIGAIL GORMAN CHIEF EXECUTIVE OFFICER 40.00 X 366589 0 41665 ELISE LAFFMAN-JOHNSON CHIEF OPERATING OFFICER 40.00 X 281675 0 24449 LISA INFELISE SR DIR, MBR SVCS 40.00 X 165789 0 24191 ALETHEA GERDING MANAGING EDITOR 40.00 X 143521 0 12350 957574 0 102655 4 0 1 0 MARKEY'S AUDIO VISUAL INC 2365 ENTERPRISE PARK PL INDIANAPOLIS IN 46218 AUDIO VISUAL 160326 1 58535 58535 JOURNALS 900099 1590762 1587243 3519 ANNUAL MEETING 900099 1421105 1421105 MEMBERSHIP DUES 900099 502325 502325 3514192 107874 107874 3096914 3084555 12359 12359 12359 MISCELLANEOUS 900099 7410 7410 7410 3700370 3510673 3519 127643 10000 10000 39541 39541 10954 10954 716300 597082 119218 902196 752038 150158 89031 89031 64433 1955 62478 98997 89128 9869 28300 28300 108004 108004 18908 18908 220533 125949 94584 195918 100773 95145 2200 2200 24052 24052 47208 36626 10582 1084926 1061492 23434 83816 83816 33408 33408 OUTSIDE SERVICES 223834 223834 MEMBERSHIP SERVICES 51000 51000 OVERHEAD ALLOCATION 0 488477 -488477 4053559 3588849 464710 0 275486 849068 2244145 766403 1533964 1477742 3565163 2015987 729999 1773132 397395 375520 6502007 6491449 0 0 X 5980478 5900452 521529 590997 6502007 6491449 6502007 6491449 -353189 342631 0 X X 1 X 0 1 0 X 41857 267198 252731 88469 58535 708790 3843480 1699602 3947101 3454758 3510673 16455614 3885337 1966800 4199832 3543227 3569208 17164404 12582 23005 31770 25728 93085 1182590 1298688 1497013 1498914 1352909 6830114 1182590 1311270 1520018 1530684 1378637 6923199 10241205 99424 74286 88823 63603 107874 434010 99424 74286 88823 63603 107874 434010 1729 5131 906 3815 7410 18991 3986490 2046217 4289561 3610645 3684492 17617405 0.58130 0.60060 0.02460 0.02300 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: INCOME FROM ACTIVITIES NOT NORMALLY RECURRING RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 4034651 4034651 351733 87933 0 0 282597 313401 311755 351733 1259486 1889229 70649 78350 77939 87933 314871 472307 186000 186000 1837219 557851 1279368 39200 26826 12374 181726 181726 0 1477742 ISHARES CORE S&P 500 1773132 C 1773132 X PART X, LINE 2: THE SOCIETY IS GENERALLY EXEMPT FROM FEDERAL INCOME TAXES UNDER THE PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. IN ADDITION, THE SOCIETY HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION UNDER SECTION 509(A) OF THE INTERNAL REVENUE CODE. THE SOCIETY IS EXEMPT FROM TAXES ON INCOME OTHER THAN UNRELATED BUSINESS INCOME. NO TAX LIABILITY FOR UNRELATED BUSINESS INCOME HAS BEEN ACCRUED AS OF DECEMBER 31, 2023, AS THE SOCIETY DID NOT EARN SIGNIFICANT NET UNRELATED BUSINESS INCOME. AS OF DECEMBER 31, 2023, THE STATUTE OF LIMITATIONS REMAINED OPEN FOR THE U.S. JURISDICTIONS IN WHICH THE SOCIETY FILES TAX RETURNS; HOWEVER, THERE ARE CURRENTLY NO EXAMINATIONS PENDING OR IN PROGRESS. IT IS THE SOCIETY'S POLICY TO RECOGNIZE INTEREST AND/OR PENALTIES RELATED TO UNCERTAINTY IN INCOME TAXES, IF ANY, IN INCOME TAX OR INTEREST EXPENSE. AS OF DECEMBER 31, 2023, THE SOCIETY HAD NO ACCRUALS FOR INTEREST AND/OR PENALTIES. 1 NORTH AMERICA 0 0 GRANTMAKING 1500 EAST ASIA AND THE PACIFIC 0 0 GRANT MAKING 2500 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING 4500 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTMAKING 500 SOUTH ASIA 0 0 GRANTMAKING 1954 0 0 0 0 0 0 10954 0 10954 STUDENT/TRAINEE TRAVEL GRANT NORTH AMERICA 2 1000 ELECTRONIC PAYMENT PRESIDENTIAL TRAINEE AWARD NORTH AMERICA 1 500 ELECTRONIC PAYMENT STUDENT/TRAINEE TRAVEL GRANT EAST ASIA AND THE PACIFIC 4 2000 ELECTRONIC PAYMENT PRESIDENTIAL TRAINEE AWARD EAST ASIA AND THE PACIFIC 1 500 ELECTRONIC PAYMENT STUDENT/TRAINEE TRAVEL GRANT EUROPE (INCLUDING ICELAND & GREENLAND) 3 1500 ELECTRONIC PAYMENT PRESIDENTIAL TRAINEE AWARD EUROPE (INCLUDING ICELAND & GREENLAND) 3 1500 ELECTRONIC PAYMENT SHEINER-BEAL PHARMACOMETRICS AWARD EUROPE (INCLUDING ICELAND & GREENLAND) 1 1500 ELECTRONIC PAYMENT STUDENT/TRAINEE TRAVEL GRANT MIDDLE EAST AND NORTH AFRICA 1 500 ELECTRONIC PAYMENT STUDENT/TRAINEE TRAVEL GRANT SOUTH ASIA 1 1954 ELECTRONIC PAYMENT 0 0 0 0 0 0 PART I, LINE 2: EACH YEAR ASCPT'S AWARDS PROGRAM PROVIDES AN ARRAY OF AWARDS THAT RECOGNIZE OUTSTANDING SCIENCE AND ACHIEVEMENT IN CLINICAL PHARMACOLOGY AND TRANSLATIONAL SCIENCE. ASCPT'S AWARDS SPAN THE CONTINUUM OF CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE, AND THERAPEUTICS. THE ARRAY OF AWARDS IS DESIGNED TO RECOGNIZE EVERY TURNING POINT IN THE CAREER PATH FROM YOUNG INVESTIGATOR TO SEASONED SCIENTIST WITH THE FOCUS ON EXCEPTIONAL ACHIEVEMENTS IN THE DIMENSIONS THAT THE AWARDS ARE FOCUSED. EACH AWARD CANDIDATE IS NOMINATED THROUGH THE SUBMISSION OF A NOMINATION PACKET THAT INCLUDES A SUMMARIZED CV AND COMPREHENSIVE ASSESSMENT OF ALL ASPECTS OF THE CANDIDATES OUTSTANDING ATTRIBUTES. ADDITIONALLY, 1 TO 3 RECOMMENDATIONS MUST BE INCLUDED FROM INDIVIDUALS AS WELL AS THE CANDIDATE'S COMPLETE CV AND HIGHLIGHTS OF NOTEWORTHY SCIENTIFIC ACCOMPLISHMENTS. AFTER THE SELECTION PROCESS IS COMPLETE, THE RECIPIENTS RECEIVE THE MONETARY AWARD, A TRAVEL STIPEND TO THE ANNUAL MEETING AND RECOGNITION DURING THE ANNUAL MEETING. 1 RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK 230 WEST 41ST ST NEW YORK NY 10036 131988190 501(C)(3) 10000 0 DARRELL ABERNETHY EARLY INVESTIGATOR AWARD 1 0 STUDENT/TRAINEE TRAVEL GRANT 35 17541 PRESIDENTIAL TRAINEE AWARD 23 11500 LEON GOLDBERG EARLY INVESTIGATOR AWARD 3 3000 GARY NEIL PRIZE 1 2500 JASON MORROW AWARD 1 1000 WILLIAM B. ABRAMS AWARD 1 1000 HENRY ELLIOTT SERVICE AWARD 1 1000 DOLORES SHOCKLEY AWARD 1 1000 RAWLS-PALMER PROGRESS IN MEDICINE AWARD 1 1000 PART I, LINE 2: EACH YEAR ASCPT'S AWARDS PROGRAM PROVIDES AN ARRAY OF AWARDS THAT RECOGNIZE OUTSTANDING SCIENCE AND ACHIEVEMENT IN CLINICAL PHARMACOLOGY AND TRANSLATIONAL SCIENCE. ASCPT'S AWARDS SPAN THE CONTINUUM OF CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE, AND THERAPEUTICS. THE ARRAY OF AWARDS IS DESIGNED TO RECOGNIZE EVERY TURNING POINT IN THE CAREER PATH FROM YOUNG INVESTIGATOR TO SEASONED SCIENTIST WITH THE FOCUS ON EXCEPTIONAL ACHIEVEMENTS IN THE DIMENSIONS THAT THE AWARDS ARE FOCUSED. EACH AWARD CANDIDATE IS NOMINATED THROUGH THE SUBMISSION OF A NOMINATION PACKET THAT INCLUDES A SUMMARIZED CV AND COMPREHENSIVE ASSESSMENT OF ALL ASPECTS OF THE CANDIDATE'S OUTSTANDING ATTRIBUTES. ADDITIONALLY, 1 TO 3 RECOMMENDATIONS MUST BE INCLUDED FROM INDIVIDUALS AS WELL AS THE CANDIDATE'S COMPLETE CV AND HIGHLIGHTS OF NOTEWORTHY SCIENTIFIC ACCOMPLISHMENTS. AFTER THE SELECTION PROCESS IS COMPLETE, THE RECIPIENTS RECEIVE A TRAVEL STIPEND TO THE ANNUAL MEETING AND RECOGNITION DURING THE ANNUAL MEETING. A MONETARY AWARD IS PRESENTED AFTER THE ANNUAL MEETING. X X X X 0 0 0 0 0 0 0 0 0 ABIGAIL GORMAN CHIEF EXECUTIVE OFFICER 366589 0 0 0 0 0 0 0 42777 0 409366 0 0 0 ELISE LAFFMAN-JOHNSON CHIEF OPERATING OFFICER 256675 0 0 0 25000 0 24449 0 810 0 306934 0 0 0 LISA INFELISE SR DIR, MBR SVCS 154789 0 0 0 11000 0 15569 0 9355 0 190713 0 0 0 ALETHEA GERDING MANAGING EDITOR 132521 0 0 0 11000 0 12350 0 984 0 156855 0 0 0 PART I, LINE 7 THE PROCESS FOR CALCULATING THE STAFF BONUS IS DEPENDENT ON PERFORMANCE AND DISCUSSIONS WITH THE COMPENSATION COMMITTEE AND THE CEO. THE CEO'S BONUS IS CALCULATED BASED ON ACHIEVEMENT OF INCENTIVE OBJECTIVES THAT ARE APPROVED BY THE COMPENSATION COMMITTEE. SHARON SWAN FORMER CEO 49858 CONSULTING SERVICES 0 FORM 990, PART VI, SECTION A, LINE 6 THE SOCIETY HAS FOUR CLASSES OF MEMBERS: FULL MEMBER, EARLY CAREER MEMBER, EMERITUS MEMBER, AND TRAINEE/STUDENT MEMBER. FULL MEMBER: FOR APPLICANTS WHO HAVE EARNED A DOCTORATE DEGREE OR EQUIVALENT IN ANY OF THE BIOMEDICAL SCIENCES. ALSO FOR APPLICANTS IN EXECUTIVE AND LEADERSHIP ROLES IN RELATED ORGANIZATIONS. APPLICANTS MUST DEMONSTRATE A SINCERE INTEREST IN, AND CONTRIBUTIONS TO, HUMAN PHARMACOLOGY AND THERAPEUTICS THROUGH PUBLICATIONS, GRANTS, PATENTS, GOVERNMENTAL REPORTS, COMPANY REPORTS, ETC. EARLY CAREER MEMBER: AN EARLY CAREER MEMBER IS A SCIENTIST IN THEIR FIRST SEVEN YEARS OF PRACTICE. EMERITUS MEMBER: EMERITUS MEMBERS HAVE COMPLETED AT LEAST 20 YEARS OF MEMBERSHIP AND HAVE REACHED THE AGE OF 65. TRAINEE/STUDENT MEMBER: FOR APPLICANTS CURRENTLY ENROLLED IN A POST-DOCTORAL TRAINING PROGRAM WHO HAVE DEMONSTRATED AN INTEREST IN HUMAN PHARMACOLOGY AND THERAPEUTICS. ALSO FOR APPLICANTS WHO ARE PURSUING A POST-BACCALAUREATE DEGREE AND WHO POSSESS AN INTEREST IN HUMAN PHARMACOLOGY AND THERAPEUTICS. FORM 990, PART VI, SECTION A, LINE 7A MEMBERS SHALL HAVE SUCH VOTING PRIVILEGES AS ARE DETERMINED FROM TIME TO TIME BY THE SOCIETY'S GOVERNING BOARD AND SHALL VOTE IN SUCH MANNER AS DETERMINED BY THE GOVERNING BOARD. FORM 990, PART VI, SECTION A, LINE 7B ANY CHANGES TO THE ORGANIZATION'S BYLAWS ARE SUBJECT TO APPROVAL BY THE FULL MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS REVIEWED IN DETAIL BY THE TREASURER OF ASCPT AND MADE AVAILABLE TO ALL MEMBERS OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C ALL ASCPT VOLUNTEER LEADERS COMPLETE A WRITTEN CONFLICT OF INTEREST DISCLOSURE. THE CEO, LEGAL COUNSEL, AND SENIOR STAFF ARE AWARE OF CONFLICTS, AND DISCUSS ANY ACTUAL OR POTENTIAL COI ISSUES. CONFLICT OF INTEREST IS DISCUSSED AT THE BEGINNING OF EVERY BOARD OF DIRECTORS CONFERENCE CALL, WITH BOARD MEMBERS BEING ASKED TO DECLARE ANY CONFLICTS AT THE BEGINNING OF THE CALL. MONITORING AND COMPLIANCE WAS DONE WITH THE ORGANIZATIONAL STAFF MEMBERS AND LEGAL COUNSEL. FORM 990, PART VI, SECTION B, LINE 15 THE ASCPT COMPENSATION COMMITTEE REVIEWS AND APPROVES THE CEO SALARY WITH COMPARABILITY DATA AND CONTEMPORANEOUS SUBSTANTIATION OF THE DECISION. THE CEO REVIEWS OTHER KEY EMPLOYEES USING COMPARABILITY DATA AND CONTEMPORANEOUS SUBSTANTIATION OF THE DECISION. DECISIONS OF THE BOARD ARE GUIDED BY A CAREFULLY ESTABLISHED AND DISCUSSED STRATEGIC PLAN. THE PLAN IS KNOWN TO THE MEMBERS AND PROGRESS IS DISCLOSED. KEY EMPLOYEES ARE EXPECTED TO MANAGE AND OPERATE ACCORDING TO THE BOARD GUIDANCE AND IN LINE WITH THE ELEMENTS OF THE STRATEGIC PLAN. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON THE ASCPT WEBSITE. FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART XII, LINE 1: THE SOCIETY PREPARES ITS FINANCIAL STATEMENTS ON THE MODIFIED CASH BASIS OF ACCOUNTING. REVENUES ARE RECOGNIZED WHEN COLLECTED RATHER THAN WHEN EARNED, AND EXPENSES ARE GENERALLY RECOGNIZED WHEN PAID RATHER THAN WHEN INCURRED. THE MODIFIED CASH BASIS OF ACCOUNTING INCLUDES THE RECORDING OF DEPRECIATION ON PROPERTY AND EQUIPMENT, AND REALIZED AND UNREALIZED GAINS AND LOSSES ON INVESTMENTS.